Comparison of positron emission tomography with 68Ga-DOTA-TATE and 18F FDG in neuroendocrine tumours

被引：0
|
作者：
Yilmaz, S. [1 ]
Demirci, E. [1 ]
Ocak, M. [2 ]
Gunes, B. [1 ]
Kabasakal, L. [1 ]
Halac, M. [1 ]
Araman, A. [2 ]
Decristoforo, C. [3 ]
Uslu, I. [1 ]
机构：
[1] Istanbul Univ, Dept Nucl Med, Cerrahpasa Fac Med, Istanbul, Turkey
[2] Istanbul Univ, Fac Pharm, Dept Pharmaceut Technol, Istanbul, Turkey
[3] Med Univ Innsbruck, Clin Dept Nucl Med, A-6020 Innsbruck, Austria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2011年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S382 / S382
页数：1
相关论文
共 50 条
  • [21] Radionuclide impurities in [18F]F- and [18F]FDG for positron emission tomography
    Koehler, M.
    Degering, D.
    Zessin, J.
    Fuechtner, F.
    Konheiser, J.
    APPLIED RADIATION AND ISOTOPES, 2013, 81 : 268 - 271
  • [22] Vasculitis assessment with [18F]FDG positron emission tomography
    Liozon, E.
    Monteil, J.
    Ly, K. H.
    Vidal, E.
    REVUE DE MEDECINE INTERNE, 2010, 31 (06): : 417 - 427
  • [23] Vasculitis assessment with [18F]FDG positron emission tomography
    Liozon, E.
    Monteil, J.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2008, 32 (10): : 511 - 522
  • [24] Comparison of radiation dosimetry of [68Ga]Ga-DOTA-TOC and [68Ga]Ga-DOTA-TATE in patients affected by neuroendocrine tumours
    Velikyan, Irina
    Sandstrom, Mattias
    Garske, Ulrike
    Sorensen, Jens
    Eriksson, Barbro
    Granberg, Dan
    Sundin, Anders
    Lubberink, Mark
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S270 - S270
  • [25] Comparison of 68Ga-DOTA-Tyr3-octreotide and 18F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients
    Putzer, D.
    Gabriel, M.
    Kendler, D.
    Henninger, B.
    Knoflach, M.
    Kroiss, A.
    Vonguggenberg, E.
    Warwitz, B.
    Virgolini, I. J.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 54 (01): : 68 - 75
  • [26] Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG Uptake in Esophageal Cancer
    Liu, Huipan
    Hu, Zhi
    Yang, Xiao
    Dai, Tianyang
    Chen, Yue
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Al[18F]F-NOTA-Octreotide Is Comparable to [68Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population
    Haeger, Arlette
    Soza-Ried, Cristian
    Kramer, Vasko
    Hurtado de Mendoza, Ana
    Eppard, Elisabeth
    Emmanuel, Noemie
    Wettlin, Johanna
    Amaral, Horacio
    Fernandez, Rene
    CANCERS, 2023, 15 (02)
  • [28] Comparison of [18F]-FDG and [18F]-NaF Positron Emission Tomography on Culprit Carotid Atherosclerosis A Prospective Study
    Kim, Jeong-Min
    Lee, Eun Seong
    Park, Kwang-Yeol
    Seok, Ju Won
    Kwon, Oh-Sang
    JACC-CARDIOVASCULAR IMAGING, 2019, 12 (02) : 370 - 372
  • [29] Role of PET / CT with 68Ga-DOTA-TATE in the evaluation of patients with gynecologic tract neuroendocrine tumors
    Silvera, E.
    Dos Santos, G.
    Savio, E.
    Alonso, O.
    Duarte, P.
    Gambini, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S376 - S377
  • [30] Clinical impact of positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) in head and neck tumours
    Ekberg, Tomas
    Sorensen, Jens
    Engstrom, Mats
    Blomquist, Erik
    Sundin, Anders
    Anniko, Matti
    ACTA OTO-LARYNGOLOGICA, 2007, 127 (02) : 186 - 193
12345